WHO ICTRP trial
HNSCC ID-3 Translational therapy monitoring of locally advanced or metastatic…
DRKS00025330 · German Clinical Trials Register · Recruiting
Key facts
| Trial ID | DRKS00025330 |
|---|---|
| Public title | HNSCC ID-3 Translational therapy monitoring of locally advanced or metastatic head and neck squamous cell carcinoma (HNSCC) with 18F-FDG PET-CT and liquid biopsy under immunotherapy |
| Scientific title | HNSCC ID-3 Translational therapy monitoring of locally advanced or metastatic head and neck squamous cell carcinoma (HNSCC) with 18F-FDG PET-CT and liquid biopsy under immunotherapy - HNSCC ID |
| Primary sponsor | Klinikum der Universität München, Campus Großhadern |
| Registry | German Clinical Trials Register |
| Recruitment status | Recruiting |
| Study type | observational |
| Countries | Germany |
| Conditions | C00 C01 C02 C03 C04 C05 C06 C07 C08 C09 C12 C13 C14 C30 C31 C32;Malignant neoplasm of lip;Malignant neoplasm of base of tongue;Malignant neoplasm of other and unspecified parts of tongue;Malignant neoplasm of gum;Malignant neoplasm of floor… |
| Interventions | Group 1: Patients with HNSCC will be examined at three time points of response assessment - at baseline, 8-12 weeks later, 6 months later - with 18F-FDG PET/CT and liquid biopsy. |
| Registration date | Aug 31, 2021 |
| Target size | 30 |
| Secondary IDs | LMU-RAD00758 |
| Registry page | drks.de |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: